137 related articles for article (PubMed ID: 34111551)
1. Removing a light-chain missing byproduct by MMC ImpRes mixed-mode chromatography under weak partitioning mode in purifying a WuXiBody-based bispecific antibody.
Zhang T; Wan Y; Duan J; Li Y
Protein Expr Purif; 2021 Oct; 186():105927. PubMed ID: 34111551
[TBL] [Abstract][Full Text] [Related]
2. Removing light chain-missing byproducts and aggregates by Capto MMC ImpRes mixed-mode chromatography during the purification of two WuXiBody-based bispecific antibodies.
Wan Y; Zhang T; Wang Y; Wang Y; Li Y
Protein Expr Purif; 2020 Nov; 175():105712. PubMed ID: 32738441
[TBL] [Abstract][Full Text] [Related]
3. A potential downstream platform approach for WuXiBody-based IgG-like bispecific antibodies.
Guo G; Han J; Wang Y; Li Y
Protein Expr Purif; 2020 Sep; 173():105647. PubMed ID: 32334139
[TBL] [Abstract][Full Text] [Related]
4. Application of pH-salt dual gradient elution in purifying a WuXiBody-based bispecific antibody by MMC ImpRes mixed-mode chromatography.
Wan Y; Wang Y; Zhang T; Zhang S; Wang Y; Li Y
Protein Expr Purif; 2021 May; 181():105822. PubMed ID: 33429037
[TBL] [Abstract][Full Text] [Related]
5. Removal of half antibody, hole-hole homodimer and aggregates during bispecific antibody purification using MMC ImpRes mixed-mode chromatography.
Tang J; Zhang X; Chen T; Wang Y; Li Y
Protein Expr Purif; 2020 Mar; 167():105529. PubMed ID: 31698035
[TBL] [Abstract][Full Text] [Related]
6. Complementary methods for monitoring hole-hole homodimer associated with a WuXiBody-based asymmetric bispecific antibody.
Dong W; Li Y
Protein Expr Purif; 2023 Oct; 210():106316. PubMed ID: 37271410
[TBL] [Abstract][Full Text] [Related]
7. Removing a difficult-to-separate byproduct by Capto L affinity chromatography during the purification of a WuXiBody-based bispecific antibody.
Wang Y; Chen X; Wang Y; Li Y
Protein Expr Purif; 2020 Nov; 175():105713. PubMed ID: 32738439
[TBL] [Abstract][Full Text] [Related]
8. Evaluating a new mixed-mode resin Diamond MMC Mustang using Capto MMC ImpRes as a benchmark.
Zhang S; Wan Y; Duan J; Li Y
Protein Expr Purif; 2021 Oct; 186():105930. PubMed ID: 34147604
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic modeling based process development for monoclonal antibody monomer-aggregate separations in multimodal cation exchange chromatography.
Zhang L; Parasnavis S; Li Z; Chen J; Cramer S
J Chromatogr A; 2019 Sep; 1602():317-325. PubMed ID: 31248584
[TBL] [Abstract][Full Text] [Related]
10. Effectively removing the homodimer in bispecific antibodies by weak partitioning mode of anion exchange chromatography.
Liang X; He Q; Qin G; Li G; Li Q; Tan H; Wang Z; Fan M; Xu D
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jun; 1225():123767. PubMed ID: 37270861
[TBL] [Abstract][Full Text] [Related]
11. Comparing the relative robustness of anion exchange and the corresponding mixed-mode chromatography on removing a weakly-bound byproduct: A case study of bispecific antibody purification.
Zhang S; Zhang T; Li Y; Wan Y
Protein Expr Purif; 2021 Nov; 187():105948. PubMed ID: 34303809
[TBL] [Abstract][Full Text] [Related]
12. IgG-like bispecific antibody platforms with built-in purification-facilitating elements.
Li Y
Protein Expr Purif; 2021 Dec; 188():105955. PubMed ID: 34416361
[TBL] [Abstract][Full Text] [Related]
13. Comparing the relative robustness of byproduct removal by wash and by elution in column chromatography for the purification of a bispecific antibody.
Wan Y; Zhang T; Wang Y; Li Y
Protein Expr Purif; 2021 Jan; 177():105762. PubMed ID: 32971297
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin-binding protein-based affinity chromatography in bispecific antibody purification: Functions beyond product capture.
Li Y
Protein Expr Purif; 2021 Dec; 188():105976. PubMed ID: 34537355
[TBL] [Abstract][Full Text] [Related]
15. Systematic workflow for studying domain contributions of bispecific antibodies to selectivity in multimodal chromatography.
Parasnavis SS; Niu B; Aspelund M; Chung WK; Snyder M; Cramer SM
Biotechnol Bioeng; 2022 Jan; 119(1):211-225. PubMed ID: 34687215
[TBL] [Abstract][Full Text] [Related]
16. A thermodynamic evaluation of antibody-surface interactions in multimodal cation exchange chromatography.
Gudhka RB; Roush DJ; Cramer SM
J Chromatogr A; 2020 Sep; 1628():461479. PubMed ID: 32822997
[TBL] [Abstract][Full Text] [Related]
17. Purification of common light chain IgG-like bispecific antibodies using highly linear pH gradients.
Sharkey B; Pudi S; Wallace Moyer I; Zhong L; Prinz B; Baruah H; Lynaugh H; Kumar S; Wittrup KD; Nett JH
MAbs; 2017; 9(2):257-268. PubMed ID: 27937066
[TBL] [Abstract][Full Text] [Related]
18. Characterization and Monitoring of a Novel Light-heavy-light Chain Mispair in a Therapeutic Bispecific Antibody.
Cao M; Parthemore C; Jiao Y; Korman S; Aspelund M; Hunter A; Kilby G; Chen X
J Pharm Sci; 2021 Aug; 110(8):2904-2915. PubMed ID: 33894207
[TBL] [Abstract][Full Text] [Related]
19. Capture and purification of an untagged nanobody by mixed weak cation chromatography and cation exchange chromatography.
Li X; Liu W; Li H; Wang X; Zhao Y
Protein Expr Purif; 2022 Apr; 192():106030. PubMed ID: 34920133
[TBL] [Abstract][Full Text] [Related]
20. Fab-based bispecific antibody formats with robust biophysical properties and biological activity.
Wu X; Sereno AJ; Huang F; Lewis SM; Lieu RL; Weldon C; Torres C; Fine C; Batt MA; Fitchett JR; Glasebrook AL; Kuhlman B; Demarest SJ
MAbs; 2015; 7(3):470-82. PubMed ID: 25774965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
